Spots Global Cancer Trial Database for minocycline
Every month we try and update this database with for minocycline cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer | NCT00473083 | Rash | Minocycline Clindamycin 2% ... Erlotinib Topical clindam... | 18 Years - | British Columbia Cancer Agency | |
| Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement | NCT01813240 | Spinal Tumors, ... | Minocycline placebo | 18 Years - 65 Years | Hadassah Medical Organization | |
| Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib | NCT06120140 | Carcinoma, Non-... | Amivantamab Lazertinib Doxycycline Minocycline Clindamycin Chlorhexidine Noncomedogenic ... | 18 Years - | Janssen Research & Development, LLC | |
| Minocycline Study in Pancreatic Cancer Patients | NCT01693523 | Pancreatic Canc... | Minocycline Placebo Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium | NCT02928692 | Prostate Cancer Carcinoma of th... Colon Cancer Renal Carcinoma | Minocycline Placebo | 65 Years - | RenJi Hospital | |
| Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. | NCT01173692 | Oropharynx Canc... | Minocycline Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma | NCT01793051 | Myeloma | Minocycline Placebo Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma | NCT01580969 | Recurrent Gliom... | Bevacizumab Minocycline Radiation | 18 Years - | University of Utah | |
| A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer | NCT01746043 | Esophageal Canc... | Armodafinil Placebo Minocycline Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement | NCT01813240 | Spinal Tumors, ... | Minocycline placebo | 18 Years - 65 Years | Hadassah Medical Organization | |
| Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients | NCT01906008 | Colorectal Canc... | Minocycline Placebo Questionnaires Sensory Test | 18 Years - | M.D. Anderson Cancer Center | |
| Prevention of Treatment Induced Neuropathy in Multiple Myeloma | NCT01283997 | Myeloma | Placebo Minocycline | 18 Years - | M.D. Anderson Cancer Center | |
| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium | NCT02928692 | Prostate Cancer Carcinoma of th... Colon Cancer Renal Carcinoma | Minocycline Placebo | 65 Years - | RenJi Hospital | |
| Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients | NCT01906008 | Colorectal Canc... | Minocycline Placebo Questionnaires Sensory Test | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer | NCT01746043 | Esophageal Canc... | Armodafinil Placebo Minocycline Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Symptom Burden in Head and Neck Cancer | NCT01219673 | Head And Neck C... | Placebo Armodafinil Minocycline Bupropion | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib | NCT06120140 | Carcinoma, Non-... | Amivantamab Lazertinib Doxycycline Minocycline Clindamycin Chlorhexidine Noncomedogenic ... | 18 Years - | Janssen Research & Development, LLC | |
| Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. | NCT01173692 | Oropharynx Canc... | Minocycline Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) | NCT01048983 | Non Small Cell ... | Armodafinil Bupropion Minocycline Curcumin Telephone Quest... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma | NCT02770378 | Glioblastoma | Temozolomide Aprepitant Minocycline Disulfiram Celecoxib Sertraline Captopril Itraconazole Ritonavir Auranofin | 18 Years - | University of Ulm | |
| Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms | NCT00243893 | Aneurysms Arteriovenous M... | minocycline doxycycline | 13 Years - 80 Years | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
